The largest database of trusted experimental protocols

Na fluor kit

Manufactured by Thermo Fisher Scientific
Sourced in United States

The NA-Fluor™ kit is a nucleic acid quantification solution designed to accurately measure the concentration of DNA or RNA in a sample. The kit utilizes a fluorescent dye that specifically binds to nucleic acids, allowing for sensitive and precise quantification.

Automatically generated - may contain errors

6 protocols using na fluor kit

1

Hemagglutination and NA Inhibition Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
Hemagglutination assay was performed using 0.75% guinea pig and 0.5% turkey RBCs (Lampire Biological Labs) (WHO, 2011 ). Viruses were two-fold serially diluted in PBS with or without oseltamivir (20 nM) and incubated at room temperature for 1h. RBCs were then added, and titers (hemagglutination units/50 μL, HAU/50 μL) were recorded after 1h incubation at room temperature.
NA inhibition (NI) assay was performed using the NA-Fluor kit (Applied Biosystems), as previously described (Okomo-Adhiambo et al., 2010b (link)). Briefly, normalized virus preparations were incubated in the presence of NA inhibitors for 45min prior to the addition of 2-(4-(methylumbelliferyl)-a-D-N-acetylneuraminic acid (MUNANA) substrate. After 1h incubation at 37°C, the reaction was terminated by the addition of the NA-Fluor stop solution and the fluorescence (excitation = 360 nm; emission = 460 nm) produced by 4-metheylumbelliferone (4-MU), a product of MUNANA cleaved by NA, was measured using Cytation 7 (Agilent-BioTek). Curve-fitting and determination of IC50 (the drug concentration required to inhibit NA activity by 50%) were done as previously described (Okomo-Adhiambo et al., 2010b (link)). Mean and standard deviation was calculated from results collected from at least three independent tests.
+ Open protocol
+ Expand
2

Quantification of Viral Infection Kinetics

Check if the same lab product or an alternative is used in the 5 most similar protocols
Control A549 cells and those treated with either Cu, TTM or esiRNA were infected at MOI = 1. Culture medium was sampled and replaced at 12-hour intervals. The titer of infectious particles was quantified by immunostaining in MDCK cells as follows: inocula were prepared by tenfold serial dilution of the samples, and subconfluent MDCK monolayers in 96 well plates were infected. After 8 hours, cells were fixed in 4% paraformaldehyde in PBS, and permeabilized with 0.1% NP-40 in PBS. Membranes were blocked with 1% non-fat dry milk, then probed with antiserum to the NP protein and a fluorescently tagged secondary antiserum, and fluorescent foci counted. Total counts of each well were taken, for at least two dilutions per sample. Dilutions showing between 5 and 500 fluorescent foci were chosen, and the fluorescent forming units (FFU) per mL calculated as an average from these multiple counts.
Neuraminidase (NA) activity in the harvested medium was quantified by NA-Fluor kit (Applied Biosystems, Foster City, CA). Serial dilutions of samples were combined with an equal volume of substrate working solution, and incubated 60 minutes. The stop solution was added and fluorescence determined in a BioTek Synergy HT reader. Fluorescence values were normalized to the titer of each sample.
+ Open protocol
+ Expand
3

Fluorescent-based Influenza Virus Susceptibility Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Chinese National Influenza Center used a fluorescence-based assay, NA-Fluor™ kit (Applied Biosystems, Foster City, CA, USA) to determine virus sensitivity to NAIs as reported [18 (link), 19 (link)]. Oseltamivir carboxylate was provided by Hoffman-La Roche (Basel, Switzerland), zanamivir was provided by Glaxo Smith Kline (Uxbrige, UK), and Fluorescent was measured using 2104 multilabel reader (Envision™, Perkin Elmer, USA) with the excitation and emission wavelengths of 355 and 450 nm.
+ Open protocol
+ Expand
4

Neuraminidase Activity Assay for Viruses

Check if the same lab product or an alternative is used in the 5 most similar protocols
Neuraminidase activity of exposed viruses was measured using a NA-Fluor kit (Applied Biosystems) according to manufacturer’s protocol. Viruses were diluted in twofold dilution steps and mixed with an equal volume of MUNANA (2′-(4-methylumbelliferyl)alpha-D-N-acetylneuraminic acid) substrate. After 1 or 2 h, the level of fluorescence was quantified with a microplate fluorimeter (TriStar2 LB942, Berthold).
+ Open protocol
+ Expand
5

Oseltamivir Resistance Assessment Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Oseltamivir carboxylate (oseltamivir; Hoffman-La Roche) was prepared in sterile distilled water and stored at -20 °C. Neuraminidase (NA) inhibitor (NAI) susceptibility was assessed by a fluorescence-based NA enzyme inhibition assay based on the NA-Fluor™ kit (Applied Biosystems, Foster City, USA). The IC50 values, the concentrations of drug required to reduce enzyme activity by 50%, were determined using GraphPad Prism 9.0 software package (GraphPad Software Inc., San Diego, CA, USA), and interpretation of IC50 values was performed using the WHO-AVWG (World Health Organization Expert Working Group on Influenza Antiviral Susceptibility Monitoring) criteria. The criteria for influenza A viruses were as follows: compared to the median IC50 value of all tested viruses by (sub)type and drug, normal inhibition was considered <10-fold, reduced inhibition was 10-to 100-fold, and highly reduced inhibition was > 100-fold (https://www.who.int/entity/wer/2012/wer8739.pdf).
+ Open protocol
+ Expand
6

Influenza Virus Neuraminidase Inhibition Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Oseltamivir carboxylate (Hoffman-La Roche, Basel, Switzerland), zanamivir (GSK, Brentford, UK) were prepared in sterile distilled water and stored in aliquots at – 20 °C until use. NA inhibitors (NAIs) susceptibility was assessed using fluorescence-based NA enzyme inhibition assay, based the NA-Fluor™ kit (Applied Biosystems, Foster City, USA), to determine 50% inhibitory concentrations (IC50). The IC50 values were determined using GraphPad Prism software (version 5.00, GraphPad Software, La Jolla, USA). The interpretation of IC50 value was performed using the criteria of the World Health Organization Expert Working Group on Influenza Antiviral Susceptibility Monitoring (WHO-AVWG). The criteria for influenza B viruses: compared to the median IC50 value of all tested viruses by (sub)type and drug, normal inhibition (NI) with < 5-fold, reduced inhibition (RI) with 5- to 50-fold, and highly reduced inhibition (HRI) with > 50-fold [16 (link)].
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!